Cargando…
LncRNA MORT (ZNF667-AS1) in Cancer—Is There a Possible Role in Gynecological Malignancies?
Gynecological cancers (GCs) are currently among the major threats to female health. Moreover, there are different histologic subtypes of these cancers, which are defined as ‘rare’ due to an annual incidence of <6 per 100,000 women. The majority of these tend to be associated with a poor prognosis...
Autores principales: | Di Fiore, Riccardo, Suleiman, Sherif, Drago-Ferrante, Rosa, Felix, Ana, O’Toole, Sharon A., O’Leary, John J., Ward, Mark P., Beirne, James, Yordanov, Angel, Vasileva-Slaveva, Mariela, Subbannayya, Yashwanth, Pentimalli, Francesca, Giordano, Antonio, Calleja-Agius, Jean |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8346052/ https://www.ncbi.nlm.nih.gov/pubmed/34360598 http://dx.doi.org/10.3390/ijms22157829 |
Ejemplares similares
-
The Role of FBXW7 in Gynecologic Malignancies
por: Di Fiore, Riccardo, et al.
Publicado: (2023) -
Cancer Stem Cells and Their Possible Implications in Cervical Cancer: A Short Review
por: Di Fiore, Riccardo, et al.
Publicado: (2022) -
An Overview of the Role of Long Non-Coding RNAs in Human Choriocarcinoma
por: Di Fiore, Riccardo, et al.
Publicado: (2021) -
Aberrant methylation and downregulation of ZNF667-AS1 and ZNF667 promote the malignant progression of laryngeal squamous cell carcinoma
por: Meng, Wenxia, et al.
Publicado: (2019) -
Could MicroRNAs Be Useful Tools to Improve the Diagnosis and Treatment of Rare Gynecological Cancers? A Brief Overview
por: Di Fiore, Riccardo, et al.
Publicado: (2021)